Delivery Order SPE2DB20D3103-SPE2DB22FP1H4

Award Date 7/7/22
Potential Completion Date 7/8/22
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,223.72 firm fixed-price contract is for the delivery of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. The award has an ultimate completion date of December 10, 2024 and was not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,596.71 firm fixed-price contract is for the delivery of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,792.32 firm fixed-price delivery order is for the supply of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. The contract has an ultimate completion date of March 14, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,384.80 firm fixed-price contract is for the delivery of 80 mg Telmisartan tablets, a medication used to treat high blood pressure and heart failure. The contract has an ultimate completion date of September 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,137.92, is for the delivery of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. The contract is a firm fixed-price delivery order with a completion date of February 20, 2025. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is the prime...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,707.94 firm fixed-price contract is for the supply of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,294.60 Firm Fixed Price delivery order is for the supply of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical. This IDC serves as a primary vehicle...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,487.86 firm fixed-price delivery order is for the supply of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,448.76 firm fixed-price delivery order is for the supply of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. The contract has an ultimate completion date of August 7, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $6,474.83, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. The award is a Firm Fixed Price Delivery Order with an ultimate completion date of March 4, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB22FP1H4
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,983.88 firm fixed-price contract is for the delivery of Telmisartan 80 mg tablets, a medication used to treat high blood pressure.

The contract is not designated as a set-aside and represents a standard open competition award. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries through streamlined contracting mechanisms.

Generated 2/27/25, 1:24 PM